Hudson Bay Capital Management Portfolio holdings
AUM
$15.2B
1-Year Return
11.47%
This Quarter Return
+8.85%
1 Year Return
+11.47%
3 Year Return
+62.45%
5 Year Return
+105.91%
10 Year Return
+214.7%
AUM
$11.4B
AUM Growth
+$924M
(+8.8%)
Cap. Flow
-$955M
Cap. Flow
% of AUM
-8.37%
Top 10 Holdings %
Top 10 Hldgs %
41.39%
Holding
914
New
180
Increased
139
Reduced
176
Closed
255
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$358M |
| 2 |
Advanced Micro Devices
AMD
|
+$341M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$305M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$144M |
| 5 |
Amazon
AMZN
|
+$127M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$685M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$254M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$221M |
| 4 |
Apple
AAPL
|
+$214M |
| 5 |
Microsoft
MSFT
|
+$163M |
Sector Composition
| 1 | Technology | 22.16% |
| 2 | Communication Services | 12.72% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Financials | 8.78% |
| 5 | Healthcare | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
FIVE9
FIVN
$2.04B
| $1.02M | 0.01% |
+12,930
| New | +$1.02M |
|
|
MNTN
427
DELISTED
Everest Consolidator Acquisition Corporation
MNTN
| $1.02M | 0.01% |
92,982
-7,018
| -7% | -$76.8K |
|
|
BZAI
428
Blaize Holdings, Inc. Common Stock
BZAI
$358M
| $1.02M | 0.01% |
94,807
-5,253
| -5% | -$56.3K |
|
429
Fortress Biotech
FBIO
$107M
| $985K | 0.01% |
+327,235
| New | +$985K |
|
430
Eos Energy Enterprises
EOSE
$1.95B
| $983K | 0.01% |
+901,710
| New | +$983K |
|
431
MP Materials
MP
$11.2B
| $979K | 0.01% |
49,310
| – | – |
|
|
DISH
432
DELISTED
DISH Network Corp.
DISH
| $928K | 0.01% |
160,831
| – | – |
|
433
IHS Holding
IHS
$2.42B
| $920K | 0.01% |
+200,000
| New | +$920K |
|
434
MoonLake Immunotherapeutics
MLTX
$3.62B
| $906K | 0.01% |
+15,000
| New | +$906K |
|
|
HA
435
DELISTED
Hawaiian Holdings, Inc.
HA
| $905K | 0.01% |
+63,707
| New | +$905K |
|
436
Olema Pharmaceuticals
OLMA
$511M
| $877K | 0.01% |
+62,500
| New | +$877K |
|
437
Scilex Holding
SCLX
$175M
| $866K | 0.01% |
12,134
-1,428
| -11% | -$102K |
|
438
Alkermes
ALKS
$4.6B
| $832K | 0.01% |
30,000
| – | – |
|
439
Aurinia Pharmaceuticals
AUPH
$1.63B
| $832K | 0.01% |
92,500
-63,984
| -41% | -$575K |
|
440
PTC Therapeutics
PTCT
$4.64B
| $827K | 0.01% |
30,000
| – | – |
|
441
Pliant Therapeutics
PLRX
$107M
| $815K | 0.01% |
+45,000
| New | +$815K |
|
442
Recursion Pharmaceuticals
RXRX
$2.05B
| $789K | 0.01% |
80,000
+40,000
| +100% | +$394K |
|
|
ETRN
443
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $786K | 0.01% |
77,228
-246,164
| -76% | -$2.51M |
|
444
BioCryst Pharmaceuticals
BCRX
$1.7B
| $779K | ﹤0.01% |
130,000
+65,000
| +100% | +$389K |
|
445
Viridian Therapeutics
VRDN
$1.65B
| $766K | ﹤0.01% |
+35,176
| New | +$766K |
|
446
NCR Atleos
NATL
$2.9B
| $759K | ﹤0.01% |
+31,261
| New | +$759K |
|
447
Prothena Corp
PRTA
$449M
| $727K | ﹤0.01% |
20,000
-12,500
| -38% | -$454K |
|
448
Tower Semiconductor
TSEM
$7.22B
| $693K | ﹤0.01% |
22,706
-146,574
| -87% | -$4.47M |
|
449
Tecnoglass
TGLS
$3.31B
| $689K | ﹤0.01% |
15,082
-106,231
| -88% | -$4.86M |
|
450
Leslie's
LESL
$62.6M
| $673K | ﹤0.01% |
+97,433
| New | +$673K |
|